Case Study
Tuesday, March 18
09:30 AM - 10:00 AM
Live in Everett
Less Details
The competitive pharmaceutical landscape and increasing global price pressures are driving companies to look at ways to bust bureaucracy and engage employees who are doing the work in ways of doing it better. Learn how one pharmaceutical company is stepping beyond traditional Product Supply Systems (PSS) to fully enable employees to own their day-to-day work and operations with an introduction to Bayer’s new operating model — Dynamic Shared Ownership (DSO). This program will feature a case study to look at how the implementation of DSO at one site builds not only on cross-functional teams working in PSS, but also on two programs designed to drive employee ownership in decision-making in the areas of asset management and a Value Improvement Program that drives efficiency and cost-savings. In this session, you will learn:
Tina Self serves as the global lead for the Biologics Manufacturing Capability Cluster, responsible for clinical through commercial manufacturing of Bayer’s biologics portfolio. She also serves as the Site Head for Bayer’s biotech campus in Berkeley, California. Prior to taking on this role in June 2024, she has advanced through positions of increasing responsibility in Quality, Biologics Manufacturing and Site Management. She is the proud leader of a fantastic team focused on manufacturing products that serve the global hemophilia community as well as producing the next generation of life-changing medicines. Tina has more than 25 years of experience with diverse product platforms including small molecule, autologous drug therapy, enzyme replacement, MABs and recombinant proteins in and has held leadership roles at Sanofi Genzyme and EMD Serono. Tina holds bachelor’s and master’s degrees from Georgia Southwestern State University and Johns Hopkins University and an MBA from Florida Atlantic University.